Endothelial Growth Factors
"Endothelial Growth Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
These growth factors are soluble mitogens secreted by a variety of organs. The factors are a mixture of two single chain polypeptides which have affinity to heparin. Their molecular weight are organ and species dependent. They have mitogenic and chemotactic effects and can stimulate endothelial cells to grow and synthesize DNA. The factors are related to both the basic and acidic FIBROBLAST GROWTH FACTORS but have different amino acid sequences.
| Descriptor ID |
D016228
|
| MeSH Number(s) |
D12.644.276.390 D12.776.467.390 D23.529.390
|
| Concept/Terms |
Endothelial Growth Factors- Endothelial Growth Factors
- Growth Factors, Endothelial
- Endo-GF
- Endothelial Growth Factor Polypeptides
- Endothelial Growth Factor
- Growth Factor, Endothelial
- ECDGF
- Endothelial Cell-Derived Growth Factors
- Endothelial Cell Derived Growth Factors
|
Below are MeSH descriptors whose meaning is more general than "Endothelial Growth Factors".
Below are MeSH descriptors whose meaning is more specific than "Endothelial Growth Factors".
This graph shows the total number of publications written about "Endothelial Growth Factors" by people in this website by year, and whether "Endothelial Growth Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 0 | 2 |
| 1995 | 4 | 0 | 4 |
| 1996 | 3 | 1 | 4 |
| 1997 | 2 | 1 | 3 |
| 1998 | 1 | 0 | 1 |
| 1999 | 5 | 0 | 5 |
| 2000 | 3 | 2 | 5 |
| 2001 | 6 | 3 | 9 |
| 2002 | 3 | 6 | 9 |
| 2003 | 2 | 2 | 4 |
| 2009 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Endothelial Growth Factors" by people in Profiles.
-
Review on the Safety and Efficacy of Brolucizumab for Neovascular Age-Related Macular Degeneration From Major Studies and Real-World Data. Asia Pac J Ophthalmol (Phila). 2023 Mar-Apr 01; 12(2):168-183.
-
Vascular characterization of clear cell sarcoma of the kidney in a child: a case report and review. J Pediatr Surg. 2009 Oct; 44(10):2031-6.
-
Topical VEGF enhances healing of thoracic aortic anastomosis for coarctation in a rabbit model. Circulation. 2003 Sep 09; 108 Suppl 1:II150-4.
-
Regression of established tumors and metastases by potent vascular endothelial growth factor blockade. Proc Natl Acad Sci U S A. 2003 Jun 24; 100(13):7785-90.
-
Prospective study of circulating angiogenic markers in prostate-specific antigen (PSA)-stable and PSA-progressive hormone-sensitive advanced prostate cancer. Urology. 2003 Apr; 61(4):765-9.
-
VEGF-induced activation of the PI3-K/Akt pathway reduces mutant SOD1-mediated motor neuron cell death. Brain Res Mol Brain Res. 2003 Mar 17; 111(1-2):155-64.
-
Interstitial flow as a guide for lymphangiogenesis. Circ Res. 2003 Apr 18; 92(7):801-8.
-
Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis. J Pediatr Surg. 2003 Mar; 38(3):308-14; discussion 308-14.
-
Vascular endothelial growth factor in the cerebrospinal fluid of infants who died of sudden infant death syndrome: evidence for antecedent hypoxia. Pediatrics. 2003 Feb; 111(2):358-63.
-
The role of interstitial stress in lymphatic function and lymphangiogenesis. Ann N Y Acad Sci. 2002 Dec; 979:197-210; discussion 229-34.